This privacy policy (“Privacy Policy”) describes how BIXAHUMAN.COM collects, uses and shares personal information when using each of the following websites https://www.BIXAHUMAN.COM (the “Site”) or our products and services (together, the “Programs”). 

Please also read the Terms of Service which sets out the terms governing the Services along with any other additional agreements, terms, guidelines or policies provided to or entered into by you that are applicable to your use of our Services. 

Your privacy is very important to us. Our Privacy Policy explains the information we collect, how we use and share it, how to manage your privacy settings and your rights in connection with the Services. 

We are based in the United States and our Services are provided to you by us. 

We will post any modifications or changes to the Privacy Policy on our Site. We reserve the right to modify the PRIVACY Policy at any time,so we encourage you to review it frequently. The “Last Updated” date indicates when this Policy was last changed. If we make any material changes to the Policy, we will post a notice on our Site.

This Privacy Policy was written in English. To the extent a translated version conflicts with the English version, the English version controls. Unless indicated otherwise, this Privacy Policy does not apply to third party products or services or the practices of companies that we do not own or control, including other companies you might interact with on or through the Services.

What is Personal Information?

We collect information about you in a range of forms, including any information which, either alone or in combination with other information we hold about you, identifies you as an individual, including, for example, your name, postal address, email address, telephone number, user name, password, demographic information and billing and payment information.

Why do we need your personal information? 

We need certain personal information in order to provide you with access to our Programs or Contact. In order to give the best attention to and access to all the programs, such as purchase or participation in one of our products or services, you will need to agree to provide us this information. By providing us this information you are consenting to our use of your information and this consent provides us with the legal basis we require under applicable law to process your data. You maintain the right to withdraw such consent at any time. If you do not agree to our use of your personal information pursuant to this Privacy Policy, please do not use our Services. 

Comments

When visitors leave comments on the site we collect the data shown in the comments form, and also the visitor’s IP address and browser user agent string to help spam detection. 

Cookies

If you leave a comment on our site you may opt-in to saving your name, email address and website in cookies. These are for your convenience so that you do not have to fill in your details again when you leave another comment. These cookies will last for one year. 

Embedded content from other websites

Articles on this site may include embedded content (e.g. videos, images, articles, etc.). Embedded content from other websites behaves in the exact same way as if the visitor has visited the other website. 

These websites may collect data about you, use cookies, embed additional third-party tracking, and monitor your interaction with that embedded content, including tracking your interaction with the embedded content if you have an account and are logged in to that website. 

How long we retain your data: If you leave a comment, the comment and its metadata are retained indefinitely. This is so we can recognize and approve any follow-up comments automatically instead of holding them in a moderation queue. 

For users that register on our website (if any), we also store the personal information they provide in their user profile. All users can see, edit, or delete their personal information at any time (except they cannot change their username). Website administrators can also see and edit that information. 

Terms of Use

Acceptance of Terms. The following terms and conditions (“Terms of Use”) govern your use of, access to, and purchase of products or services from our online and mobile websites, platforms, and applications owned and operated by BIXA PHARMACEUTICAL RESEARCH LAB, LLC dba BIXAHUMAN RESEARCH LAB. 

Severability. If any provision of the Terms of Use is held to be invalid or unenforceable by any law, rule, order, or regulation of any government or by the final determination of any state or federal court, all remaining provisions hereof will remain in full force and effect. 

Choice of Law. By accessing the site you agree that the statutes, laws, and regulations of the United States and the State of New York, USA, without regard to conflicts of law principles, will apply to all matters relating to use of the site, and you agree that any
litigation shall be subject to the exclusive jurisdiction of the State or Federal Courts in Florida. 

Marketing Dietary Supplements

Under the Dietary Supplements Health and Education Act (DSHEA), the manufacturer of a dietary supplement or dietary ingredient is responsible for ensuring that the product is safe before marketing. Once a product has reached the U.S. market, the U.S. Food and Drug Administration (FDA) is responsible for monitoring safety and has the authority to remove any unsafe dietary supplement product. Products marketed in the U.S. prior to the passage of DSHEA (1994) are assumed to have a history of safe use (i.e., “grandfathered”). 

Supplement manufacturers introducing a new dietary ingredient to the U.S. market, defined as “a dietary ingredient that was not marketed in the United States before October 15, 1994” must notify the FDA of its intent 75 days before doing so. This pre-market review period allows FDA to examine the available safety data for the new ingredient and, if necessary, to request more information or to deny marketing of the dietary supplement containing the new ingredient. “Old” dietary ingredients (those marketed as a dietary supplement prior to October 15, 1994) are presumed to be safe and no notification is required. Manufacturers including claims on the label of a dietary supplement must have substantiation to ensure that the claim is truthful and not misleading. FDA has published guidance detailing the amount and nature of the substantiation manufacturers should have. 

In July 2011, FDA published a draft guidance for industry intended to assist in the determination of when premarket notification for a dietary supplement containing a new dietary ingredient was necessary in preparing a New Dietary Ingredient (NDI) notification.

Following the issuance of this draft guidance (July 2011), concern was expressed by the trade associations representing dietary supplement manufacturers, as well as consumers, that FDA appeared to be attempting to shift the enforcement burden from the agency to the manufacturers, creating significant bureaucratic hurdles to new product innovations and market availability. In June 2012, FDA agreed that it needed to substantially revise the guidance to address the concerns voiced by industry.

In August 2016, FDA released a revised draft of the NDI Guidance. CHPA submitted comments to FDA noting a number of proposals in the Guidance that could impede product/ingredient innovation by responsible companies and make it difficult to introduce
new products. 

Advertising Dietary Supplements

As for all products on the market, advertising for dietary supplements must be truthful and substantiated. The U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) work together in regulating dietary supplement advertising. FDA is
primarily responsible for claims on product labeling, while FTC has primary responsibility for claims in advertising, including print and broadcast ads, infomercials, catalogs, and similar direct marketing materials. These two agencies collaborate to ensure consistency in dietary supplement advertising regulation. 

Claims describing the role of a dietary supplement in supporting wellness are allowed on dietary supplement labels provided the manufacturer has evidence substantiating these claims and notifies FDA of the claim within 30 days of marketing the product. In some instances, the dietary supplement must contain the following disclaimer on the label: “This statement has not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”
There are three types of permissible claims for dietary supplements: health claims, structure/function claims, and nutrient content claims.

● Health claims describe a relationship between a food, food component, or dietary supplement ingredient and reduction in the risk of a disease or health-related condition. An example of a health claim is “a healthful diet with adequate folate may reduce a woman’s risk of having a child with a brain or spinal cord defect. 

● A structure/function claim describes the role of a nutrient or dietary ingredient in affecting the normal structure or function of the human body. Examples of structure function claims include “helps promote urinary tract health”, “helps maintain cardiovascular function”, and “promotes relaxation”. 

● Lastly, nutrient content claims describe the level of a nutrient or dietary substance in the product, using terms such as “free”, “high”, and “low”. The majority of nutrient content claims apply to ingredients with an established daily value (e.g., Vitamin C, calcium). An example of this would be that a supplement with at least 12 mg of Vitamin C per serving could state on its label that the product is an “Excellent source of Vitamin C”.